Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.
Sign Up to like & getrecommendations! Published in 2020 at "European urology oncology"
DOI: 10.1016/j.euo.2020.06.007
Abstract: The PRECISION trial was a multicentre randomised study that demonstrated that multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy is superior to standard transrectal ultrasound-guided biopsy for the detection of prostate cancer. The outcomes of studies reporting… read more here.
Keywords: precision trial; quality; trial; scoring system ... See more keywords
THE IMPACT OF BASELINE LEFT VENTRICULAR HYPERTROPHY ON CLINICAL OUTCOMES IN THE PRECISION TRIAL
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)30956-2
Abstract: Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular (CV) mortality. The PRECISION trial evaluated the CV safety of celecoxib and nonselective NSAIDs. We assessed the contemporary impact of LVH on CV outcomes… read more here.
Keywords: precision trial; trial; ventricular hypertrophy; impact ... See more keywords
ATRIAL FIBRILLATION INCIDENCE, PREVALENCE, AND RISK FACTORS IN THE PRECISION TRIAL: A COHORT STUDY
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)30946-5
Abstract: Robust prospective RCT data on the development of clinical atrial fibrillation (AF) are sparse. We studied the incidence, prevalence and risk factors (RF) for AF in patients enrolled in the PRECISION trial. The PRECISION trial… read more here.
Keywords: incidence prevalence; prevalence risk; risk factors; atrial fibrillation ... See more keywords